Form D · Other
Adaptogens, a Public Benefit Corp
Boulder, CO · CIK 0001875718
Offering snapshot reported Oct 12, 2021 · SEC filing
- Reported sold
- $233K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 27, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2021 | Initial | $233,068 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-416601
Source: Form D, filed Oct 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lopa Kay Van Der Mersch | Director, Executive |
| Stephan Van Der Mersch | Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
907 12 Th St
Boulder, CO, 80302
Boulder, CO, 80302